NEVPF

Abliva AB

USOTC

Add Alert

NEVPF

Abliva AB

USOTC

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Chrisny73

05/19/21 1:08 PM

Post #12

Re: #11: @Renee - NeuroVive Pharmaceutical AB changed to Abliva AB

Hi. I was wandering if you were invested in this stock or are you just following it? I've been watching it for a while

Renee

05/28/20 9:06 PM

Post #11

NeuroVive Pharmaceutical AB changed to Abliva AB

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Golden Cross PremiumMember

02/19/20 2:02 PM

Post #10

Re: #9: @Chrisny73 - Looks like a buying opportunity here

Just might be...thanks for the alert Chrisny73... GL...$NEVPF

Chrisny73

02/19/20 1:25 PM

Post #9

Re: #8: @Golden Cross - $NEVPF Tier_Change: OTCQX International to Pink Current

Looks like a buying opportunity here

Golden Cross PremiumMember

01/02/20 2:36 AM

Post #8

$NEVPF Tier_Change: OTCQX International to Pink Current

OTCM Link
https://www.otcmarkets.com/stock/NEVPF/disclosure

Chrisny73

06/04/19 12:17 PM

Post #7

Re: #6: @Chrisny73 - cents to a dollar here.....

Such little volume here we won't be able to sustain this price leval for long

Chrisny73

05/17/19 1:04 PM

Post #6

Re: #5: @Chrisny73 - Looking for an entry point at .10

cents to a dollar here.....

Chrisny73

05/17/19 1:03 PM

Post #5

Re: #4: @Chrisny73 - Orphan drug huge

Looking for an entry point at .10

Chrisny73

05/17/19 1:01 PM

Post #4

Re: #3: @Chrisny73 - Lotsa potential here

Orphan drug huge

Chrisny73

05/17/19 12:59 PM

Post #3

Re: #2: @Chrisny73 - Looking for a possible entry point at like

Lotsa potential here

Chrisny73

05/14/19 12:15 PM

Post #2

Re: #1: @Chrisny73 - Looks like this stock has potential.... orphan drug

Looking for a possible entry point at like .09 or less

Chrisny73

05/14/19 12:13 PM

Post #1

Looks like this stock has potential.... orphan drug status looks like opportunity

Abliva AB (NEVPF)

Followers	0	Posters	3
Posts (Today)	0	Posts (Total)	12
Created	05/11/19	Type	Free
Moderators

NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase I (KL1333) for genetic mitochondrial diseases and one project in preparation for a clinical phase II efficacy study for the prevention of moderate to severe traumatic brain injury (NeuroSTAT). The R&D portfolio also consists of projects for genetic mitochondrial disorders, NASH and cancer. The company advances drugs for rare diseases through clinical development into the market with our without partners. For projects for common indications the goal is out-licensing in the preclinical phase. A subset of compounds under NeuroVive's NVP015 program was in 2018 licenced to Fortify Therapeutics, a BridgeBio company, for local treatment of Leber's Hereditary Optic Neuropathy (LHON). NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF).